Normal View Dyslexic View

Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open-label randomised controlled trial.

Liu Q, Li M, Gao Y, Jiang T, Han B, Zhao G et al.
BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
Lancet Gastrohepatol 2024; 9: 428-437.
Some 161 patients were included in the study. Postoperative hospital stay was shorter after robotic surgery (median 11 vs 35 days, P=0.029). Ninety-day readmission rates were similar. There was one in-hospital death in each group.
Comment: This is a common finding after robotic surgery.

Related articles


Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial.

Bang JY, Lakhtakia S, Thakkar S, Buxbaum JL, Waxman I, Sutton B et al, on behalf of the United States Pancreatic Disease Study Group.

16 August 2024

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen J-H, Biorserud C, Bjornsson B et al, for the Nordic Pancreatic Cancer Trial-1 study group.

30 August 2024
Copied!